Perioperative Parameter and Treatment Outcomes of ECIRS in Asia

Launched by CHINESE UNIVERSITY OF HONG KONG · Jun 7, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Perioperative Parameter and Treatment Outcomes of ECIRS in Asia," is studying how effective a specific surgical procedure called Endoscopic Combined Intrarenal Surgery (ECIRS) is for patients with kidney stones. The trial is collecting information from patients who are undergoing this procedure at various hospitals across Asia. By gathering this data, researchers aim to understand better how patients respond to the treatment and the overall outcomes.

To be eligible for this trial, participants must have kidney stones and agree to take part in the study. They should be undergoing the ECIRS procedure specifically for their kidney stones and not for other conditions like cancer. Patients whose surgical records are incomplete or who have had other procedures that are not part of the study will not be included. If you join the study, you can expect to have your medical information tracked as part of the research, which could help improve future treatments for kidney stones. This trial is currently recruiting participants of all genders, aged between 65 and 74.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with urinary calculi
• • Undergoing Endoscopic Combined Intrarenal Surgery (ECIRS)
• • Agreed to consent for the study
• Exclusion Criteria:
• • Patients who have ECIRS for other conditions, such as urothelial cancer etc.
• • Patients who intraoperative record was incomplete.
• • Patients only have either PCNL or ureteroscopy done (not both)